458.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$463.74
Offen:
$458.7
24-Stunden-Volumen:
131.33K
Relative Volume:
0.21
Marktkapitalisierung:
$37.97B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$887.87M
KGV:
43.01
EPS:
10.67
Netto-Cashflow:
$808.08M
1W Leistung:
-2.02%
1M Leistung:
+9.82%
6M Leistung:
-4.34%
1J Leistung:
-18.83%
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IDXX
Idexx Laboratories Inc
|
459.35 | 37.97B | 3.90B | 887.87M | 808.08M | 10.67 |
![]()
TMO
Thermo Fisher Scientific Inc
|
537.38 | 208.55B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
198.36 | 144.98B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
138.33 | 40.44B | 6.51B | 1.29B | 1.37B | 4.42 |
![]()
IQV
Iqvia Holdings Inc
|
196.40 | 35.38B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
2024-07-25 | Eingeleitet | BTIG Research | Buy |
2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-07-25 | Herabstufung | Stifel | Buy → Hold |
2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
2021-02-17 | Eingeleitet | Barclays | Overweight |
2019-09-09 | Eingeleitet | Goldman | Neutral |
2019-05-23 | Eingeleitet | Guggenheim | Buy |
2018-11-02 | Bestätigt | BofA/Merrill | Buy |
2018-05-07 | Bestätigt | Stifel | Buy |
2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
2017-07-28 | Hochstufung | CL King | Neutral → Buy |
2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
2016-08-16 | Bestätigt | Stifel | Buy |
2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
2016-04-01 | Eingeleitet | CL King | Neutral |
2016-03-21 | Bestätigt | Stifel | Buy |
2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
2015-10-29 | Bestätigt | Stifel | Buy |
2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2015-08-13 | Bestätigt | Stifel | Buy |
2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Marks Group Wealth Management Inc Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4 - Yahoo Finance
IDEXX Laboratories Independent Director M. Szostak Sells 49% Of Holding - Simply Wall St
Spire Wealth Management Reduces Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories executive vice president sells $4.6 million in stock By Investing.com - Investing.com Australia
Idexx Laboratories executive vice president sells $4.6 million in stock - Investing.com India
Thompson Investment Management Inc. Takes $310,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
M. Anne Szostak Implements A Sell Strategy: Offloads $1.40M In IDEXX Laboratories Stock - Benzinga
Equitable Trust Co. Buys Shares of 1,635 IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Moloney Securities Asset Management LLC Invests $374,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Sells $1,397,820.00 in Stock - MarketBeat
Idexx Laboratories director sells $1.4 million in shares - MSN
Are Options Traders Betting on a Big Move in IDEXX (IDXX) Stock? - MSN
State of Alaska Department of Revenue Lowers Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories And Its Real Value (NASDAQ:IDXX) - Seeking Alpha
Piper Sandler Boosts IDEXX Laboratories (NASDAQ:IDXX) Price Target to $510.00 - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Apollon Wealth Management LLC - MarketBeat
Piper Sandler Adjusts IDEXX Laboratories Price Target to $510 From $435, Maintains Neutral Rating - Marketscreener.com
Sumitomo Mitsui Trust Group Inc. Raises Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Entropy Technologies LP Purchases 2,259 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Why Idexx Labs Stock Rocketed Higher This Week - MSN
Ninety One UK Ltd Has $29.37 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Leerink Partnrs Has Pessimistic Outlook of IDXX Q1 Earnings - MarketBeat
StockNews.com Downgrades IDEXX Laboratories (NASDAQ:IDXX) to Hold - MarketBeat
Robinson Value Management Ltd. Buys New Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Stephens Investment Management Group LLC - MarketBeat
632 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by Weaver Capital Management LLC - MarketBeat
FY2024 EPS Forecast for IDEXX Laboratories Lifted by Analyst - MarketBeat
DAVENPORT & Co LLC Acquires 1,321 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Harvey Investment Co. LLC Sells 650 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Lecap Asset Management Ltd. - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Sells 4,108 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Expands By 7.1% - MarketBeat
Barclays Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
Q1 EPS Estimates for IDEXX Laboratories Cut by William Blair - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Caprock Group LLC - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future - Seeking Alpha
China Universal Asset Management Co. Ltd. Lowers Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Chicago Capital LLC Has $35.63 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
SYM FINANCIAL Corp Purchases New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Paragon Capital Management Inc. - MarketBeat
IDEXX Laboratories, Inc. : Idexx Laboratories looks set for an upward trend -February 05, 2025 at 04:26 am EST - Marketscreener.com
IDEXX Laboratories, Inc. Provides Financial Guidance for 2025 -February 03, 2025 at 06:30 am EST - Marketscreener.com
IDEXX Laboratories (IDXX) Reports an “Amazing Quarter” – Jim Cramer Calls It a “Safety Stock” - Insider Monkey
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends By Investing.com - Investing.com South Africa
IDEXX Laboratories’ SWOT analysis: stock outlook amid vet visit trends By Investing.com - Investing.com Nigeria
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $535.00 - MarketBeat
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):